The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Protein kinase C, an elusive therapeutic target?
Open accessAbstract
Protein kinase C (PKC) has been a tantalizing target for drug discovery ever since it was first identified as the receptor for the tumour promoter phorbol ester in 1982. Although initial therapeutic efforts focused on cancer, additional indications — including diabetic complications, heart failure, myocardial infarction, pain and bipolar disorder — were targeted as researchers developed a better understanding of the roles of eight conventional and novel PKC isozymes in health and disease. Unfortunately, both academic and pharmaceutical efforts have yet to result in the approval of a single new drug that specifically targets PKC. Why does PKC remain an elusive drug target? This Review provides a short account of some of the efforts, challenges and opportunities in developing PKC modulators to address unmet clinical needs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Protein Kinase C: Structure, Function, and Regulation
Newton, A. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28495 · Cited by 1,655
Function-Oriented Synthesis, Step Economy, and Drug Design
Wender, P. A., Verma, V. A., Paxton, T. J., & Pillow, T. H. (2008) · Accounts of Chemical Research · doi:10.1021/ar700155p · Cited by 1,204
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Coussens, L., Parker, P. J., Rhee, L., Yang-Feng, T. L., Chen, E., Waterfield, M. D., Francke, U., & Ullrich, A. (1986) · Science · doi:10.1126/science.3755548 · Cited by 1,042
Protein Kinase C Contains a Pseudosubstrate Prototope in Its Regulatory Domain
House, C., & Kemp, B. E. (1987) · Science · doi:10.1126/science.3686012 · Cited by 997
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
Protein kinase C and other diacylglycerol effectors in cancer
Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978
Localization of Protein Kinases by Anchoring Proteins: a Theme in Signal Transduction
Mochly-Rosen, D. (1995) · Science · doi:10.1126/science.7716516 · Cited by 906
Self-citationStructural Basis of Protein Kinase C Isoform Function
Steinberg, S. F. (2008) · Physiological Reviews · doi:10.1152/physrev.00034.2007 · Cited by 872
The Complete Primary Structure of Protein Kinase C—the Major Phorbol Ester Receptor
Parker, P. J., Coussens, L., Totty, N., Rhee, L., Young, S., Chen, E., Stabel, S., Waterfield, M. D., & Ullrich, A. (1986) · Science · doi:10.1126/science.3755547 · Cited by 854
Rottlerin, a Novel Protein Kinase Inhibitor
Gschwendt, M., Muller, H. J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G., & Marks, F. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1199 · Cited by 841
Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart
Chen, C.-H., Budas, G. R., Churchill, E. N., Disatnik, M.-H., Hurley, T. D., & Mochly-Rosen, D. (2008) · Science · doi:10.1126/science.1158554 · Cited by 767
Self-citationTakai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731
Ron, D., Chen, C. H., Caldwell, J., Jamieson, L., Orr, E., & Mochly-Rosen, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.839 · Cited by 723
Self-citationThe structure, expression, and properties of additional members of the protein kinase C family.
Ono, Y., Fujii, T., Ogita, K., Kikkawa, U., Igarashi, K., & Nishizuka, Y. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68732-0 · Cited by 692
Preconditioning protects ischemic rabbit heart by protein kinase C activation
Ytrehus, K., Liu, Y., & Downey, J. M. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.3.h1145 · Cited by 615
Ross, A. M., Gibbons, R. J., Stone, G. W., Kloner, R. A., & Alexander, R. W. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.061 · Cited by 610
Activation of protein kinase C by tyrosine phosphorylation in response to H 2 O 2
Konishi, H., Tanaka, M., Takemura, Y., Matsuzaki, H., Ono, Y., Kikkawa, U., & Nishizuka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11233 · Cited by 605
Takai, Y., Kishimoto, A., Inoue, M., & Nishizuka, Y. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41009-x · Cited by 595
PKC-α regulates cardiac contractility and propensity toward heart failure
Braz, J. C., Gregory, K., Pathak, A., Zhao, W., Sahin, B., Klevitsky, R., Kimball, T. F., Lorenz, J. N., Nairn, A. C., Liggett, S. B., et al. (2004) · Nature Medicine · doi:10.1038/nm1000 · Cited by 595
Caspase signalling controls microglia activation and neurotoxicity
Burguillos, M. A., Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., et al. (2011) · Nature · doi:10.1038/nature09788 · Cited by 585
Coordination of Three Signaling Enzymes by AKAP79, a Mammalian Scaffold Protein
Klauck, T. M., Faux, M. C., Labudda, K., Langeberg, L. K., Jaken, S., & Scott, J. D. (1996) · Science · doi:10.1126/science.271.5255.1589 · Cited by 550
Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC
Chen, L., Hahn, H., Wu, G., Chen, C.-H., Liron, T., Schechtman, D., Cavallaro, G., Banci, L., Guo, Y., Bolli, R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191369098 · Cited by 538
Self-citationIsoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C
Wilkinson, S. E., Parker, P. J., & Nixon, J. S. (1993) · Biochemical Journal · doi:10.1042/bj2940335 · Cited by 522
The missing link: A single unifying mechanism for diabetic complications
Nishikawa, T., Edelstein, D., & Brownlee, M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07705.x · Cited by 510
Fischer, T., Stone, R. M., DeAngelo, D. J., Galinsky, I., Estey, E., Lanza, C., Fox, E., Ehninger, G., Feldman, E. J., Schiller, G. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9678 · Cited by 504
Identification of intracellular receptor proteins for activated protein kinase C.
Mochly-Rosen, D., Khaner, H., & Lopez, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3997 · Cited by 498
Self-citationIn vitro studies on the mode of action of the phorbol esters, potent tumor promoters: Part 1
Blumberg, P. M., & Boutwell, R. K. (1980) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448009037493 · Cited by 471
Bowling, N., Walsh, R. A., Song, G., Estridge, T., Sandusky, G. E., Fouts, R. L., Mintze, K., Pickard, T., Roden, R., Bristow, M. R., et al. (1999) · Circulation · doi:10.1161/01.cir.99.3.384 · Cited by 457
Kraft, A. S., Anderson, W. B., Cooper, H. L., & Sando, J. J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33427-6 · Cited by 412
Gray, M. O., Karliner, J. S., & Mochly-Rosen, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30945 · Cited by 390
Self-citationJulier, K., da Silva, R., Garcia, C., Bestmann, L., Frascarolo, P., Zollinger, A., Chassot, P.-G., Schmid, E. R., Turina, M. I., von Segesser, L. K., et al. (2003) · Anesthesiology · doi:10.1097/00000542-200306000-00004 · Cited by 381
Dorn, G. W., Souroujon, M. C., Liron, T., Chen, C.-H., Gray, M. O., Zhou, H. Z., Csukai, M., Wu, G., Lorenz, J. N., & Mochly-Rosen, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12798 · Cited by 359
Self-citationLocalization of Protein Kinase C Isozymes in Cardiac Myocytes
Disatnik, M.-H., Buraggi, G., & Mochly-Rosen, D. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1041 · Cited by 333
Self-citationRole of cytokines in inflammatory process in Parkinson’s disease
Sawada, M., Imamura, K., & Nagatsu, T. (2006) · Parkinson’s Disease and Related Disorders · doi:10.1007/978-3-211-45295-0_57 · Cited by 331
[28] Use and specificity of staurosporine, UCN-O1, and calphostin C as protein kinase inhibitors
Tamaoki, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01030-6 · Cited by 330
C2 Region-derived Peptides Inhibit Translocation and Function of β Protein Kinase C in Vivo
Ron, D., Luo, J., & Mochly-Rosen, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24180 · Cited by 319
Self-citationExpression and Properties of Two Types of Protein Kinase C: Alternative Splicing from a Single Gene
Ono, Y., Kikkawa, U., Ogita, K., Fujii, T., Kurokawa, T., Asaoka, Y., Sekiguchi, K., Ase, K., Igarashi, K., & Nishizuka, Y. (1987) · Science · doi:10.1126/science.3576226 · Cited by 311
Rottlerin: an inappropriate and ineffective inhibitor of PKCδ
Soltoff, S. P. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.07.003 · Cited by 311
Protein Kinase Czeta (PKCzeta): Activation Mechanisms and Cellular Functions
Hirai, T. (2003) · Journal of Biochemistry · doi:10.1093/jb/mvg017 · Cited by 304
Goodnight, J., Mischak, H., Kolch, W., & Mushinski, J. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9991 · Cited by 300
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes
Tuttle, K. R., Bakris, G. L., Toto, R. D., McGill, J. B., Hu, K., & Anderson, P. W. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2686 · Cited by 300
Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.032 · Cited by 276
Protein kinase C isoforms: Multi-functional regulators of cell life and death
Reyland, M. (2009) · Frontiers in Bioscience · doi:10.2741/3385 · Cited by 266
Inhibition of δ-Protein Kinase C Protects Against Reperfusion Injury of the Ischemic Heart In Vivo
Inagaki, K., Chen, L., Ikeno, F., Lee, F. H., Imahashi, K.-I., Bouley, D. M., Rezaee, M., Yock, P. G., Murphy, E., & Mochly-Rosen, D. (2003) · Circulation · doi:10.1161/01.cir.0000101682.24138.36 · Cited by 265
Self-citationTargeting Protein–Protein Interactions for Therapeutic Intervention: A Challenge for the Future
Zinzalla, G., & Thurston, D. E. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.12 · Cited by 260
Qi, X., Disatnik, M.-H., Shen, N., Sobel, R. A., & Mochly-Rosen, D. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-06-0551 · Cited by 258
Self-citationA protein kinase C isozyme is translocated to cytoskeletal elements on activation.
Mochly‐Rosen, D., Henrich, C. J., Cheever, L., Khaner, H., & Simpson, P. C. (1990) · Cell Regulation · doi:10.1091/mbc.1.9.693 · Cited by 255
Self-citationKraft, A. S., Smith, J. B., & Berkow, R. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1334 · Cited by 252
Prekeris, R., Mayhew, M. W., Cooper, J. B., & Terrian, D. M. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.77 · Cited by 247
PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease
Alkon, D. L., Sun, M.-K., & Nelson, T. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.002 · Cited by 243
Konishi, H., Yamauchi, E., Taniguchi, H., Yamamoto, T., Matsuzaki, H., Takemura, Y., Ohmae, K., Kikkawa, U., & Nishizuka, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111158798 · Cited by 242
Robertson, M. J., Kahl, B. S., Vose, J. M., de Vos, S., Laughlin, M., Flynn, P. J., Rowland, K., Cruz, J. C., Goldberg, S. L., Musib, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3146 · Cited by 232
Bowman, J. C., Steinberg, S. F., Jiang, T., Geenen, D. L., Fishman, G. I., & Buttrick, P. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119755 · Cited by 229
Peptide modulators of protein–protein interactions in intracellular signaling
Souroujon, M. C., & Mochly-Rosen, D. (1998) · Nature Biotechnology · doi:10.1038/nbt1098-919 · Cited by 221
Self-citationThe PKC-DRS Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2188 · Cited by 218
Yildiz, A., Guleryuz, S., Ankerst, D. P., Öngür, D., & Renshaw, P. F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.43 · Cited by 213
Bacher, N., Zisman, Y., Berent, E., & Livneh, E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.126 · Cited by 213
Mochly-Rosen, D., Khaner, H., Lopez, J., & Smith, B. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98554-6 · Cited by 211
Self-citationEfficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study
Zarate, C. A., Singh, J. B., Carlson, P. J., Quiroz, J., Jolkovsky, L., Luckenbaugh, D. A., & Manji, H. K. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00530.x · Cited by 208
Structural Basis for Chk1 Inhibition by UCN-01
Zhao, B., Bower, M. J., McDevitt, P. J., Zhao, H., Davis, S. T., Johanson, K. O., Green, S. M., Concha, N. O., & Zhou, B.-B. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201233200 · Cited by 206
Mechanism of action of the phorbol ester tumor promoters: Specific receptors for lipophilic ligands
Blumberg, P. M., Jaken, S., König, B., Sharkey, N. A., Leach, K. L., Jeng, A. Y., & Yeh, E. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90448-9 · Cited by 204
Inagaki, K., Hahn, H. S., Dorn, G. W., & Mochly-Rosen, D. (2003) · Circulation · doi:10.1161/01.cir.0000081943.93653.73 · Cited by 202
Self-citationThe Role of Protein Kinase C in Cerebral Ischemic and Reperfusion Injury
Bright, R., & Mochly-Rosen, D. (2005) · Stroke · doi:10.1161/01.str.0000189996.71237.f7 · Cited by 202
Self-citationMechanism of Cardioprotection by Early Ischemic Preconditioning
Yang, X., Cohen, M. V., & Downey, J. M. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6236-x · Cited by 200
An autoregulatory region in protein kinase C: the pseudoanchoring site.
Ron, D., & Mochly-Rosen, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.492 · Cited by 199
Self-citationMurriel, C. L., Churchill, E., Inagaki, K., Szweda, L. I., & Mochly-Rosen, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405071200 · Cited by 198
Self-citationDirect Inhibition of δ-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI) Investigators (2008) · Circulation · doi:10.1161/circulationaha.107.759167 · Cited by 195
Altered platelet protein kinase C activity in bipolar affective disorder, manic episode
Friedman, E., Hoau-Yan-Wang, Levinson, D., Connell, T. A., & Singh, H. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90006-y · Cited by 194
Protein kinase C in heart failure: a therapeutic target?
Palaniyandi, S. S., Sun, L., Ferreira, J. C. B., & Mochly-Rosen, D. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp001 · Cited by 193
Self-citationPhilip, P. A., Rea, D., Thavasu, P., Carmichael, J., Stuart, N. S. A., Rockett, H., Talbot, D. C., Ganesan, T., Pettit, G. R., Balkwill, F., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.22.1812 · Cited by 187
Binding Specificity for RACK1 Resides in the V5 Region of βII Protein Kinase C
Stebbins, E. G., & Mochly-Rosen, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101044200 · Cited by 183
Self-citationProtein kinase C inhibitors as novel anticancer drugs
Jirousek, M. R., & Goekjian, P. G. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.12.2117 · Cited by 182
Takeishi, Y., Chu, G., Kirkpatrick, D. M., Li, Z., Wakasaki, H., Kranias, E. G., King, G. L., & Walsh, R. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2709 · Cited by 179
Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation
HARPER, M. T., & POOLE, A. W. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03722.x · Cited by 178
Vinik, A. I., Bril, V., Kempler, P., Litchy, W. J., Tesfaye, S., Price, K. L., & Bastyr, E. J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.08.001 · Cited by 171
Manji, H. K., Bebchuk, J. M., Moore, G. J., Glitz, D. A., Hasanat, K., & Chen, G. (1999) · PubMed · Cited by 170
De Hert, S., Vlasselaers, D., Barbé, R., Ory, J., Dekegel, D., Donnadonni, R., Demeere, J., Mulier, J., & Wouters, P. (2009) · Anaesthesia · doi:10.1111/j.1365-2044.2009.06008.x · Cited by 169
Enhanced protein kinase C activity and translocation in bipolar affective disorder brains
Wang, H.-Y., & Friedman, E. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00611-7 · Cited by 168
Myocardial Damage Prevented by Volatile Anesthetics: A Multicenter Randomized Controlled Study
Guarracino, F., Landoni, G., Tritapepe, L., Pompei, F., Leoni, A., Aletti, G., Scandroglio, A. M., Maselli, D., De Luca, M., Marchetti, C., et al. (2006) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2006.05.012 · Cited by 167
Protein kinase C inhibits amyloid β‐peptide neurotoxicity by acting on members of the Wnt pathway
Garrido, J. L., Godoy, J., Alvarez, A., Bronfman, M., & Inestrosa, N. C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0327fje · Cited by 163
Budas, G. R., Churchill, E. N., & Mochly‐Rosen, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.04.005 · Cited by 156
Self-citationPKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
Bézy, O., Tran, T. T., Pihlajamäki, J., Suzuki, R., Emanuelli, B., Winnay, J., Mori, M. A., Haas, J. T., Biddinger, S. B., Leitges, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46045 · Cited by 154
Paz-Ares, L. G., Douillard, J., Koralewski, P., Manegold, C., Smit, E. F., Reyes, J. M., Chang, G., John, W. J., Peterson, P. M., Obasaju, C. K., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3299 · Cited by 154
A Preliminary Investigation of a Protein Kinase C Inhibitor in the Treatment of Acute Mania
Bebchuk, J. M., Arfken, C. L., Manji, S., Murphy, J., Hasanat, K., & Manji, H. K. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.95 · Cited by 152
Hambleton, M., Hahn, H. S., Pleger, S. T., Kuhn, M., Klevitsky, R., Carr, A. N., Kimball, T. F., Hewett, T. E., Dorn, G. W., Koch, W. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.592550 · Cited by 152
Effect of Ruboxistaurin in Patients With Diabetic Macular Edema
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.318 · Cited by 151
Epsilon protein kinase C as a potential therapeutic target for the ischemic heart
Inagaki, K., Churchill, E. N., & Mochly‐Rosen, D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.015 · Cited by 150
Self-citationReduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412
Campochiaro, P. A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0955 · Cited by 144
Pkc-Drs, G. B. (2005) · Clinical Diabetology · Cited by 144
Protein kinase Cε: an oncogene and emerging tumor biomarker
Gorin, M. A., & Pan, Q. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-9 · Cited by 140
Zhang, D., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124669 · Cited by 139
Role of Protein Kinase C in Ischemic Preconditioning: Player or Spectator?
Brooks, G., & Hearse, D. J. (1996) · Circulation Research · doi:10.1161/01.res.79.3.628 · Cited by 138
Multiple isoforms of a protein kinase C inhibitor (KCIP‐1/14‐3‐3) from sheep brain
Toker, A., Sellers, L. A., Amess, B., PATEL, Y., Harris, A., & Aitken, A. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16946.x · Cited by 136
Two Faces of Protein Kinase Cδ: The Contrasting Roles of PKCδ in Cell Survival and Cell Death
Basu, A., & Pal, D. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.214 · Cited by 135
Suzuki, A., Akimoto, K., & Ohno, S. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg018 · Cited by 134
Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder
Hahn, C., & Friedman, E. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.010204.x · Cited by 131
Budas, G. R., Churchill, E. N., Disatnik, M., Sun, L., & Mochly‐Rosen, D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq154 · Cited by 131
Self-citationChurchill, E. N., Murriel, C. L., Chen, C., Mochly‐Rosen, D., & Szweda, L. I. (2005) · Circulation Research · doi:10.1161/01.res.0000173896.32522.6e · Cited by 130
Self-citationCASELLINI, C. M., Barlow, P. M., Rice, A. L., Casey, M. A., Simmons, K. E., Pittenger, G. L., Bastyr, E. J., Wolka, A. M., & Vinik, A. I. (2007) · Diabetes Care · doi:10.2337/dc06-1699 · Cited by 129
STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development
Limnander, A., Depeille, P., Freedman, T. S., Liou, J., Leitges, M., Kurosaki, T., Roose, J. P., & Weiss, A. (2011) · Nature Immunology · doi:10.1038/ni.2016 · Cited by 128
Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen.
Couldwell, W. T., Hinton, D. R., Surnock, A. A., DeGiorgio, C. M., Weiner, L. P., Apuzzo, M. L. J., Masri, L. E., Law, R. E., & Weiss, M. H. (1996) · PubMed · Cited by 126
Opposing roles of δ and εPKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery
Murriel, C. L., & Mochly‐Rosen, D. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.038 · Cited by 126
Self-citationCardioprotection by ε-Protein Kinase C Activation From Ischemia
Inagaki, K., Begley, R., Ikeno, F., & Mochly‐Rosen, D. (2004) · Circulation · doi:10.1161/01.cir.0000151614.22282.f1 · Cited by 126
Self-citationProtein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder
Zarate, C. A., & Manji, H. K. (2009) · CNS Drugs · doi:10.2165/00023210-200923070-00003 · Cited by 122
Einat, H., Yuan, P., Szabo, S. T., Dogra, S., & Manji, H. K. (2007) · Neuropsychobiology · doi:10.1159/000106054 · Cited by 122
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
DeMets, D. L., & Califf, R. M. (2002) · Circulation · doi:10.1161/01.cir.0000023220.26465.89 · Cited by 122
Protein kinase Cα: disease regulator and therapeutic target
Konopatskaya, O., & Poole, A. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.006 · Cited by 121
A Novel Neuroprotective Mechanism of Riluzole: Direct Inhibition of Protein Kinase C
Noh, K., Hwang, J.-Y., Shin, H., & Koh, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0297 · Cited by 120
Packer, M., The Principal Investigators of the Reflect Study, Narahara, K. A., Elkayam, U., Sullivan, J. M., Pearle, D. L., Massie, B. M., & Creager, M. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90816-j · Cited by 119
Tolcher, A. W., Reyno, L. M., Venner, P. M., Ernst, S., Moore, M. J., Geary, R. S., Chi, K., Hall, S. R. R., Walsh, W., Dorr, A., et al. (2002) · PubMed · Cited by 119
Connelly, K. A., Kelly, D. J., Zhang, Y., Prior, D., Advani, A., Cox, A. J., Thai, K., Krum, H., & Gilbert, R. E. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.765750 · Cited by 116
Szállási, Z., Denning, M. F., Smith, C. B., Dlugosz, A. A., Yuspa, S. H., Pettit, G. R., & Blumberg, P. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09823-2 · Cited by 116
Exploitation of protein kinase C: A useful target for cancer therapy
Ali, A. S., Ali, S. S., El‐Rayes, B. F., Philip, P. A., & Sarkar, F. H. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.006 · Cited by 112
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
Kreisl, T. N., Kotliarova, S. E., Butman, J. A., Albert, P. S., Kim, L., Musib, L. C., Thornton, D., & Fine, H. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop042 · Cited by 112
Rationally designed peptide regulators of protein kinase C
Churchill, E. N., Qvit, N., & Mochly‐Rosen, D. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.002 · Cited by 105
Self-citationPKC-delta and PKC-epsilon: Foes of the same family or strangers?
Duquesnes, N., Lezoualc’h, F., & Crozatier, B. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.013 · Cited by 103
Cardiac protection by volatile anaesthetics
Tritapepe, L., Landoni, G., Guarracino, F., Pompei, F., Crivellari, M., Maselli, D., Luca, M. D., Fochi, O., DʼAvolio, S., Bignami, E. G., et al. (2006) · European Journal of Anaesthesiology · doi:10.1017/s0265021506001931 · Cited by 103
Kheifets, V., & Mochly‐Rosen, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.04.014 · Cited by 102
Self-citationThe nature of bipolar disorder.
Manji, H. K., & Lenox, R. H. (2000) · PubMed · Cited by 102
Wender, P. A., Baryza, J. L., Brenner, S. E., DeChristopher, B. A., Loy, B. A., Schrier, A. J., & Verma, V. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015270108 · Cited by 101
Pravdić, D., Sedlić, F., Mio, Y., Vladic, N., Bienengraeber, M., & Bosnjak, Z. J. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181a91957 · Cited by 101
A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer.
Bergan, R. C., Reed, E., Myers, C. E., Headlee, D. J., Brawley, O. W., Cho, H. K., Figg, W. D., Tompkins, A. C., Linehan, W. M., Köhler, D., et al. (1999) · PubMed · Cited by 100
Adenosine Myocardial Protection
Mentzer, R. M., Birjiniuk, V., Khuri, S. F., Lowe, J. E., Rahko, P. S., Weisel, R. D., Wellons, H. A., Barker, M. L., & Lasley, R. D. (1999) · Annals of Surgery · doi:10.1097/00000658-199905000-00006 · Cited by 98
García‐Bermejo, L., Leskow, F. C., Fujii, T., Wang, Q. J., Blumberg, P. M., Ohba, M., Kuroki, T., Han, K., Lee, J., Márquez, V. E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107639200 · Cited by 97
Morschhauser, F., Seymour, J. F., Kluin‐Nelemans, H. C., Grigg, A., Wolf, M., Pfreundschuh, M. G., Tilly, H., Raemaekers, J. M. M., Veer, M. B. V., Milpied, N. J., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm463 · Cited by 97
Cripps, M. C., Figueredo, A. T., Oza, A. M., Taylor, M. J., Fields, A. L. A., Holmlund, J. T., McIntosh, L., Geary, R. S., & Eisenhauer, E. A. (2002) · PubMed · Cited by 96
ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN
Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., Wolka, A. M., Shahri, N., & Milton, R. C. (2011) · Retina · doi:10.1097/iae.0b013e3182111669 · Cited by 96
Amrollahi, Z., Rezaei, F., Salehi, B., Modabbernia, A., Maroufi, A., Esfandiari, G.-R., Naderi, M., Ghebleh, F., Abhari, S. A. A., Sadeghi, M., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.015 · Cited by 94
Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease
Tuttle, K. R., McGill, J. B., Haney, D. J., Lin, T. E., & Anderson, P. W. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00840207 · Cited by 94
Wang, H.-Y., Markowitz, P., Levinson, D. F., Undie, A. S., & Friedman, E. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90057-7 · Cited by 92
Architecture and dynamics of an A-kinase anchoring protein 79 (AKAP79) signaling complex
Gold, M. G., Stengel, F., Nygren, P. J., Weisbrod, C. R., Bruce, J. E., Robinson, C. V., Barford, D., & Scott, J. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014400108 · Cited by 91
Post-Reperfusion Myocardial Infarction
Mangano, D. T., Miao, Y., Tudor, I. C., & Dietzel, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.044 · Cited by 90
Protein Kinase C as a Therapeutic Target
Teicher, B. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0945 · Cited by 90
Swannie, H., & Kaye, S. B. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0046-7 · Cited by 89
Churchill, E. N., Ferreira, J. C. B., Brum, P. C., Szweda, L. I., & Mochly‐Rosen, D. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp334 · Cited by 87
Self-citationChapline, C., Cottom, J. E., Tobin, H., Hulmes, J. D., Crabb, J. W., & Jaken, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19482 · Cited by 86
A phase II study of bryostatin 1 in metastatic malignant melanoma
Propper, D., Macaulay, V. M., O'Byrne, K. J., Braybrooke, J. P., Wilner, S., Ganesan, T., Talbot, D., & Harris, A. L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.680 · Cited by 83
Alternative Splicing Increases the Diversity of the Human Protein Kinase C Family
Coussens, L. M., Rhee, L. M., Parker, P. J., & Ullrich, A. (1987) · DNA · doi:10.1089/dna.1987.6.389 · Cited by 82
A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.
Zonder, J. A., Shields, A. F., Zalupski, M. M., Chaplen, R., Heilbrun, L. K., Arlauskas, P., & Philip, P. A. (2001) · PubMed · Cited by 82
Friman, S., Arns, W., Nashan, B., Vincenti, F., Banas, B., Budde, K., Cibrik, D. M., Chan, L. K., Klempnauer, J. L., Mulgaonkar, S., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03538.x · Cited by 80
Toward the identification of selective modulators of protein kinase C (PKC) isozymes
Shindo, M., Irie, K., Nakahara, A., Ohigashi, H., Konishi, H., Kikkawa, U., Fukuda, H., & Wender, P. A. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00100-6 · Cited by 79
PKC-θ function at the immunological synapse: prospects for therapeutic targeting
Zanin‐Zhorov, A., Dustin, M. L., & Blazar, B. R. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.007 · Cited by 79
Protein Kinase C ϵ and γ: Involvement in Formalin-Induced Nociception in Neonatal Rats
Sweitzer, S. M., Wong, S. M. E., Peters, M. C., Mochly‐Rosen, D., Yeomans, D. C., & Kendig, J. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060350 · Cited by 79
Self-citationZimmermann, J., Caravatti, G., Mett, H., Meyer, T., Müller, M., Lydon, N., & Fabbro, D. (1996) · Archiv der Pharmazie · doi:10.1002/ardp.19963290707 · Cited by 77
Effects of Knockout of the Protein Kinase C β Gene on Glucose Transport and Glucose Homeostasis1
Standaert, M. L., Bandyopadhyay, G. K., Galloway, L. C., Soto, J., Ono, Y., Kikkawa, U., Farese, R. V., & Leitges, M. (1999) · Endocrinology · doi:10.1210/endo.140.10.7073 · Cited by 77
Protein kinase Cα as a heart failure therapeutic target
Liu, Q., & Molkentin, J. D. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.004 · Cited by 76
Welch, S. A., Hirte, H. W., Carey, M. S., Hotte, S. J., Tsao, M., Brown, S., Pond, G. R., Dancey, J. E., & Oza, A. M. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.02.018 · Cited by 75
Pharmacology of protein kinase C activators: Cognition-enhancing and antidementic therapeutics
Sun, M., & Alkon, D. L. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.001 · Cited by 74
Dempsey, E. C., Cool, C. D., & Littler, C. M. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.04.010 · Cited by 74
Kim, J., Thorne, S. H., Sun, L., Huang, B., & Mochly‐Rosen, D. (2010) · Oncogene · doi:10.1038/onc.2010.415 · Cited by 68
Self-citationOh, Y. W., Herbst, R. S., Burris, H. A., Cleverly, A., Musib, L. C., Lahn, M., & Bepler, G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3685 · Cited by 68
Ajani, J. A., Jiang, Y., Faust, J., Chang, B. B., Ho, L., Yao, J. C., Rousey, S. R., Dakhil, S. R., Cherny, R. C., Craig, C. M., et al. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-6452-1 · Cited by 65
The link between PKCα regulation and cellular transformation
Michie, A. M., & Nakagawa, R. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.08.013 · Cited by 65
Ferreira, J. C. B., Brum, P. C., & Mochly‐Rosen, D. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.020 · Cited by 64
Self-citationHuang, L., Wolska, B. M., Montgomery, D. E., Burkart, E. M., Buttrick, P. M., & Solaro, R. J. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.5.c1114 · Cited by 64
BRAUN, M. U., & Mochly‐Rosen, D. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00142-1 · Cited by 62
Self-citationPKC-β is not necessary for cardiac hypertrophy
Roman, B. B., Geenen, D. L., Leitges, M., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.5.h2264 · Cited by 62
Qi, X., Inagaki, K., Sobel, R. A., & Mochly‐Rosen, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32636 · Cited by 61
Self-citationLanglois, A., Chouinard, F., Flamand, N., Ferland, C., Rola‐Pleszczynski, M., & Laviolette, M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0808492 · Cited by 60
Robins, H. I., Won, M., Seiferheld, W. F., Schultz, C. J., Choucair, A. K., Brachman, D. G., Demas, W. F., & Mehta, M. P. (2006) · Neuro-Oncology · doi:10.1215/s1522851705000311 · Cited by 59
Inagaki, K., Koyanagi, T., Berry, N. C., Sun, L., & Mochly‐Rosen, D. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.109637 · Cited by 57
Self-citationOpposing Effects of δ and ξ PKC in Ethanol-induced Cardioprotection
Chen, C., & Mochly‐Rosen, D. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1330 · Cited by 57
Self-citationPKCδ activation mediates angiogenesis via NADPH oxidase activity in PC‐3 prostate cancer cells
Kim, J., Koyanagi, T., & Mochly‐Rosen, D. (2010) · The Prostate · doi:10.1002/pros.21310 · Cited by 55
Self-citationThe therapeutic role of targeting protein kinase C in solid and hematologic malignancies
Podar, K., Raab, M. S., Chauhan, D., & Anderson, K. C. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.10.1693 · Cited by 54
Millward, M. J., House, C. M., Bowtell, D. D. L., Webster, L. K., Olver, I., Gore, M. E., Copeman, M. C., Lynch, K., Yap, A., Wang, Y., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603331 · Cited by 54
Lynch, T. J., Raju, R., Lind, M., Riviere, A., Gatzemeier, U., Dorr, A., Holmlund, J., Yuen, A. R., & Sikic, B. I. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)91766-1 · Cited by 54
Centrosomal PKCβII and Pericentrin Are Critical for Human Prostate Cancer Growth and Angiogenesis
Kim, J., Choi, Y., Vallentin, A., Hunrichs, B. S., Hellerstein, M. K., Peehl, D. M., & Mochly‐Rosen, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6195 · Cited by 54
Self-citationBosco, R., Melloni, E., Celeghini, C., Rimondi, E., Vaccarezza, M., & Zauli, G. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711795049899 · Cited by 53
Ferreira, J. C. B., Boer, B. P. N., Grinberg, M., Brum, P. C., & Mochly‐Rosen, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033175 · Cited by 52
Self-citationUsha, L., Sill, M. W., Darcy, K. M., et al. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.02.013 · Cited by 50
Ikeno, F., Inagaki, K., Rezaee, M., & Mochly‐Rosen, D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.12.011 · Cited by 50
Self-citationKu, G. Y., Ilson, D. H., Schwartz, L. H., Capanu, M., O'Reilly, E. M., Shah, M. A., Kelsen, D. P., & Schwartz, G. K. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0677-y · Cited by 50
Measurement of Reactive Oxygen Species in Cells and Mitochondria
Armstrong, J. S., & Whiteman, M. (2007) · Methods in cell biology · doi:10.1016/s0091-679x(06)80018-x · Cited by 49
Bright, R., Steinberg, G. K., & Mochly‐Rosen, D. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.113 · Cited by 49
Self-citationA multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer
Madhusudan, S., Protheroe, A. S., PROPPER, D. J., Han, C., Corrie, P. G., Earl, H. M., Hancock, B. W., Vasey, P. A., Turner, A., Balkwill, F. R., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601321 · Cited by 48
Newman, M. F., Ferguson, T. B., White, J. A., Ambrosio, G., Koglin, J., Nussmeier, N. A., Pearl, R. G., Pitt, B., Wechsler, A. S., Weisel, R. D., et al. (2012) · JAMA · doi:10.1001/jama.2012.7633 · Cited by 48
Diazgranados, N., & Zarate, C. A. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0081-7 · Cited by 47
Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery?
Belhomme, D., Peynet, J., Florens, E., Tibourtine, O., Kitakaze, M., & Menasché, P. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01502-2 · Cited by 47
Protein kinase Cε as a cancer marker and target for anticancer therapy
Totoń, E., Ignatowicz, E., Skrzeczkowska, K., & Rybczyńska, M. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70395-4 · Cited by 46
Cole, D. C., Asselin, M., Brennan, A., Czerwiński, R., Ellingboe, J. W., Fitz, L. J., Greco, R., Huang, X., Joseph‐McCarthy, D., Kelly, M. F., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800214a · Cited by 46
Dowlati, A., Lazarus, H. M., Hartman, P. H., Jacobberger, J. W., Whitacre, C. M., Gerson, S. L., Ksenich, P., Cooper, B., Frisa, P. S., Gottlieb, M. A., et al. (2003) · PubMed · Cited by 46
Treatment of patients with metastatic melanoma with bryostatin-1 - phase II study
González, R., Ebbinghaus, S., Henthorn, T. K., Miller, D. M., & Kraft, A. S. (1999) · Melanoma Research · doi:10.1097/00008390-199912000-00010 · Cited by 45
Protein Kinase C-β as a Therapeutic Target in Breast Cancer
SLEDGEJR, G., & Gökmen‐Polar, Y. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.03.019 · Cited by 44
Caino, M. C., López‐Haber, C., Kim, J., Mochly‐Rosen, D., & Kazanietz, M. G. (2011) · Oncogene · doi:10.1038/onc.2011.428 · Cited by 43
Self-citationAcadesine, an adenosine-regulating agent with the potential for widespread indications
Drew, B. G., & Kingwell, B. A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.12.2137 · Cited by 43
Tanaka, M., Terry, R. D., Mokhtari, G. K., Inagaki, K., Koyanagi, T., Kofidis, T., Mochly‐Rosen, D., & Robbins, R. C. (2004) · Circulation · doi:10.1161/01.cir.0000138389.22905.62 · Cited by 43
Self-citationPhase II Study of Bryostatin 1 in Patients with Relapsed Multiple Myeloma
Varterasian, M. L., Pemberton, P., Hulburd, K., Rodriguez, D. H., Murgo, A. J., & Al-Katib, A. M. (2001) · Investigational New Drugs · doi:10.1023/a:1010676719178 · Cited by 42
Adwan, T. S., Ohm, A. M., Jones, D. N. M., Humphries, M. J., & Reyland, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255950 · Cited by 42
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer
Winegarden, J. A. (2003) · Lung Cancer · doi:10.1016/s0169-5002(02)00447-6 · Cited by 42
Koyanagi, T., Noguchi, K., Ootani, A., Inagaki, K., Robbins, R. C., & Mochly‐Rosen, D. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.06.003 · Cited by 41
Self-citationLam, A. P., Sparano, J. A., Vinciguerra, V. P., Ocean, A. J., Christos, P. J., Höchster, H. S., Camacho, F., Goel, S., Mani, S., & Kaubisch, A. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181a31920 · Cited by 41
Márquez, V. E., Nacro, K., Benzaria, S., Lee, J., Sharma, R., Teng, K., Milne, G. W. A., Bienfait, B., Wang, S., Lewin, N. E., et al. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00048-5 · Cited by 40
Cited by
Ros and ros-mediated cellular signaling
Zhang, J., Wang, X., Vikash, V., Ye, Q., Wu, D., Liu, Y., & Dong, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4350965 · Cited by 1,980
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915
PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis
Zhang, H.-L., Hu, B.-X., Li, Z.-L., Du, T., Shan, J.-L., Ye, Z.-P., Peng, X.-D., Li, X., Huang, Y., Zhu, X.-Y., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00818-3 · Cited by 582
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Metadata
- Authors
- Mochly-Rosen, D., Das, K., & Grimes, K. V.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-11-30
- Volume
- 11
- Issue
- 12
- Pages
- 937-957
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2004585452
- Cited by
- 563
- References
- 226
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.